Clinical trial
A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on…
NCT00308282 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00308282 |
|---|---|
| Title | A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis |
| Official title | Phase II Study of Safety and Efficacy of Intravenous LY2127399 in Patients With Rheumatoid Arthritis Treated With Methotrexate |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | LY2127399, Placebo |
| Enrollment | 136 |
| Start date | Mar 28, 2006 |
| Primary completion | Jun 18, 2007 |
| Completion | Oct 18, 2007 |
| First posted | Mar 29, 2006 |
| Last update posted | Sep 10, 2019 |
| Countries | Romania |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: